NeuroTherapia, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neurotherapia.com
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- NeuroTherapia, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06194552
- Locations
- 🇺🇸
NeuroTherapia, Gates Mills, Ohio, United States
ðŸ‡ðŸ‡ºCRU Early Phase Unit Kistarcsa, Kistarcsa, Hungary
Safety and Tolerability of NTRX-07 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pain, Neuropathic
- Interventions
- Drug: NTRX-07-SDD
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- NeuroTherapia, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04375436
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
© Copyright 2025. All Rights Reserved by MedPath